1/25
07:12 am
ortx
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy [Yahoo! Finance]
Neutral
Report
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy [Yahoo! Finance]
1/25
07:00 am
ortx
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Neutral
Report
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
1/24
05:12 am
ortx
Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases [Yahoo! Finance]
Neutral
Report
Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases [Yahoo! Finance]
1/24
05:01 am
ortx
Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases
Neutral
Report
Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases
1/24
05:00 am
ortx
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Neutral
Report
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
1/19
02:03 pm
ortx
Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR [Seeking Alpha]
Low
Report
Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR [Seeking Alpha]
1/8
05:01 pm
ortx
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
Low
Report
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
1/8
05:01 pm
ortx
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
Low
Report
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
1/24
05:34 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Secor Alicia
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Secor Alicia
1/24
05:30 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: GERAGHTY JAMES A
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: GERAGHTY JAMES A
1/24
05:28 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: THOMAS FRANK E
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: THOMAS FRANK E
1/24
05:26 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Rowland Charles A Jr
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Rowland Charles A Jr
1/24
05:20 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Beck Joanne T.
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Beck Joanne T.
1/24
05:18 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Dunoyer Marc
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Dunoyer Marc
1/24
05:18 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Gaspar Bobby
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Gaspar Bobby
1/24
05:17 pm
ortx
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Altschuler Steven
Neutral
Report
Form 4 Orchard Therapeutics For: Jan 24 Filed by: Altschuler Steven
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register